作者: Susan Hiraki , Erica S. Rinella , Freya Schnabel , Ruth Oratz , Harry Ostrer
DOI: 10.1007/S10897-014-9695-6
关键词:
摘要: With the completion of Human Genome Project and development high throughput technologies, such as next-generation sequencing, use multiplex genetic testing, in which multiple genes are sequenced simultaneously to test for one or more conditions, is growing rapidly. Reflecting underlying heterogeneity where a broad range confer risks cancers, cancer panels assess these represents just example how testing being applied clinically. There number issues challenges consider when conducting risk assessment, become exceedingly complex moving from traditional single-gene approach panel testing. Here, we address practical considerations clinical breast, ovarian, colon including benefits, limitations challenges, counseling issues, management guidelines.